Inke S.A: APIs manufacturing plant.
01 1INKE SA
02 1Dr. Reddy's Laboratories Limited
03 1TAPI Hungary Industries Kft.
04 1AX Pharmaceutical Corp
05 1Aurobindo Pharma Limited
06 1Cadila Pharmaceuticals Limited
07 4Cambrex Charles City, Inc
08 1Cipla Ltd.
09 1HIKAL LIMITED
10 1Ipca Laboratories Limited
11 1LETCO MEDICAL, LLC
12 1Medisca Inc.
13 1Natco Pharma Limited
14 1Professional Compounding Centers of America
15 3Professional Compounding Centers of America dba PCCA
16 1SMS Pharmaceuticals Limited
17 1SUN PHARMACEUTICAL INDUSTRIES, INC.
18 1ScinoPharm Taiwan Ltd.
19 1Shodhana Laboratories Private Limited
20 1Symed Labs Limited
21 1Teva Pharmaceutical Works Private Limited Company
01 6ONDANSETRON HYDROCHLORIDE
02 1Ondansetron
03 1Ondansetron HCl
04 1Ondansetron HCl Dihydrate
05 16Ondansetron Hydrochloride
06 1Ondansetron Hydrochloride Dihydrate
01 1Canada
02 11India
03 2Israel
04 1Spain
05 1Taiwan
06 6U.S.A
07 2United Kingdom
08 2Blank
Inke S.A: APIs manufacturing plant.
NDC Package Code : 64567-0005
Start Marketing Date : 2009-08-19
End Marketing Date : 2027-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-017
Start Marketing Date : 2010-01-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
NDC Package Code : 84671-1025
Start Marketing Date : 2017-11-17
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53104-7540
Start Marketing Date : 2018-11-15
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-2415
Start Marketing Date : 2007-06-29
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 51927-0075
Start Marketing Date : 2020-07-21
End Marketing Date : 2027-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 51927-4320
Start Marketing Date : 2008-10-28
End Marketing Date : 2027-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 51846-1025
Start Marketing Date : 2017-11-17
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-0385
Start Marketing Date : 2026-02-17
End Marketing Date : 2027-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
NDC Package Code : 51927-0386
Start Marketing Date : 2026-02-25
End Marketing Date : 2027-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
43
PharmaCompass offers a list of Ondansetron Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ondansetron Hydrochloride manufacturer or Ondansetron Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ondansetron Hydrochloride manufacturer or Ondansetron Hydrochloride supplier.
PharmaCompass also assists you with knowing the Ondansetron Hydrochloride API Price utilized in the formulation of products. Ondansetron Hydrochloride API Price is not always fixed or binding as the Ondansetron Hydrochloride Price is obtained through a variety of data sources. The Ondansetron Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ondansetron HCl Dihydrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ondansetron HCl Dihydrate, including repackagers and relabelers. The FDA regulates Ondansetron HCl Dihydrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ondansetron HCl Dihydrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ondansetron HCl Dihydrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ondansetron HCl Dihydrate supplier is an individual or a company that provides Ondansetron HCl Dihydrate active pharmaceutical ingredient (API) or Ondansetron HCl Dihydrate finished formulations upon request. The Ondansetron HCl Dihydrate suppliers may include Ondansetron HCl Dihydrate API manufacturers, exporters, distributors and traders.
click here to find a list of Ondansetron HCl Dihydrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ondansetron HCl Dihydrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ondansetron HCl Dihydrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ondansetron HCl Dihydrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ondansetron HCl Dihydrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ondansetron HCl Dihydrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ondansetron HCl Dihydrate suppliers with NDC on PharmaCompass.
We have 20 companies offering Ondansetron HCl Dihydrate
Get in contact with the supplier of your choice:
